Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-6.93%
operating margin TTM
-7.26%
revenue TTM
1.40 Billion
revenue per share TTM
13.28$
valuation ratios | |
|---|---|
| pe ratio | -15.82 |
| peg ratio | 0.02 |
| price to book ratio | 1.57 |
| price to sales ratio | 1.22 |
| enterprise value multiple | -132.36 |
| price fair value | 1.57 |
profitability ratios | |
|---|---|
| gross profit margin | 58.56% |
| operating profit margin | -7.26% |
| pretax profit margin | -6.63% |
| net profit margin | -6.93% |
| return on assets | -4.29% |
| return on equity | -9.96% |
| return on capital employed | -5.33% |
liquidity ratios | |
|---|---|
| current ratio | 4.42 |
| quick ratio | 2.62 |
| cash ratio | 1.14 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 403.38 |
| operating cycle | 492.60 |
| days of payables outstanding | 22.74 |
| cash conversion cycle | 469.86 |
| receivables turnover | 4.09 |
| payables turnover | 16.05 |
| inventory turnover | 0.90 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.33 |
| debt equity ratio | 0.68 |
| long term debt to capitalization | 0.36 |
| total debt to capitalization | 0.41 |
| interest coverage | -2.45 |
| cash flow to debt ratio | -0.09 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.25 |
| cash per share | 7.48 |
| operating cash flow per share | -0.87 |
| free cash flow operating cash flow ratio | 1.43 |
| cash flow coverage ratios | -0.09 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -2.30 |
Frequently Asked Questions
When was the last time Sarepta Therapeutics, Inc. (NASDAQ:SRPT) reported earnings?
Sarepta Therapeutics, Inc. (SRPT) published its most recent earnings results on 05-08-2026.
What is Sarepta Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Sarepta Therapeutics, Inc. (NASDAQ:SRPT)'s trailing twelve months ROE is -9.96%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Sarepta Therapeutics, Inc. (SRPT) currently has a ROA of -4.29%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did SRPT's net profit margin stand at?
SRPT reported a profit margin of -6.93% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is SRPT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 4.42 in the most recent quarter. The quick ratio stood at 2.62, with a Debt/Eq ratio of 0.68.